Sorcin Can Trigger Pancreatic Cancer-Associated New-Onset Diabetes through the Secretion of Inflammatory Cytokines Such as Serpin E1 and CCL5

Scientists identified a gene SRI, which possessed a single nucleotide polymorphism with the potential to distinguish pancreatic cancer-associated new-onset diabetes and type 2 diabetes mellitus by machine learning. In vitro and in vivo, sorcin overexpression induced pancreatic β-cell dysfunction.